Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma.

Ruichao ChaiGuanzhang LiYuqing LiuKenan ZhangZheng ZhaoFan WuYuzhou ChangBo PangJingjun LiYangfang LiTao Jiang Yong-Zhi Wang

Published in: Cancer biology & medicine (2021)

MGMT promoter methylation has predictive value in IDH-mutant glioblastoma, but its cutoff value should be higher than that for IDH-wildtype glioblastoma.

Keyphrases

wild type
dna methylation
low grade
genome wide
gene expression
newly diagnosed